Hypercoagulability and high residual platelet reactivity in ACS patients on dual antiplatelet therapy

被引:0
作者
Paniccia, R. [1 ]
Marcucci, R. [1 ]
Attanasio, M. [1 ]
Grifoni, E. [1 ]
Priora, R. [2 ]
Ahmed, Y. [1 ]
Giglioli, C. [2 ]
Abbate, R. [3 ]
Gensini, G. F. [3 ,4 ]
机构
[1] Univ Florence, Expt & Clin Med, Florence, Italy
[2] Careggi Hosp, Florence, Italy
[3] Univ Florence, Florence, Italy
[4] Don Carlo Gnocchi Fdn, Florence, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO076-TUE
引用
收藏
页码:535 / 536
页数:2
相关论文
共 50 条
  • [31] Enhanced platelet activation is associated with increased residual platelet aggregation in patients treated with dual antiplatelet therapy
    Bigalke, B.
    Geisler, T.
    Stellos, K.
    Bischofs, C.
    Jahntz, C.
    Kremmer, E.
    Seizer, P.
    May, A. E.
    Lindemann, S.
    Gawaz, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 608 - 608
  • [32] Comparison of four tests to assess platelet reactivity in patients under dual antiplatelet therapy
    Navarro-Nunez, L.
    Pastor, F.
    Lozano, M.
    Marin, F.
    Hurtado, J.
    Roldan, V
    Martinez, C.
    Vicente, V.
    Valdes, M.
    Rivera, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 570 - 570
  • [33] Prognostic Implications of High Platelet Reactivity as Defined by Multiple Agonists in Diabetes Mellitus Patients on Dual Antiplatelet Therapy
    Angiolillo, Dominick
    Bernardo, Esther
    Capranzano, Piera
    Sabate, Manel
    Jimenez-Quevedo, Pilar
    Ferreiro, Jose Luis
    Alfonso, Fernando
    Hernandez, Rosana
    Macaya, Carlos
    Fernandez-Ortiz, Antonio
    Bass, Theodore A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A68 - A68
  • [34] Predictors of High On-Aspirin Platelet Reactivity in High-Risk Vascular Patients Treated With Single or Dual Antiplatelet Therapy
    Amsallem, Myriam
    Manzo-Silberman, Stephane
    Dillinger, Jean-Guillaume
    Sideris, Georgios
    Voicu, Sebastian
    Sollier, Claire Bal Dit
    Drouet, Ludovic
    Henry, Patrick
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (09) : 1305 - 1310
  • [35] Platelet hyper-reactivity following cessation of dual antiplatelet therapy
    Jaeger, B.
    Andric, T.
    Wojta, J.
    Huber, K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S250 - S250
  • [36] Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Verdoia, Monica
    Daffara, Veronica
    Pergolini, Patrizia
    Rolla, Roberta
    Marino, Paolo
    Bellomo, Giorgio
    Carriero, Alessandro
    De Luca, Giuseppe
    VASCULAR PHARMACOLOGY, 2017, 93-95 : 42 - 47
  • [37] VITAMIN D BINDING PROTEIN RS7041 POLYMORPHISM AND HIGH-RESIDUAL PLATELET REACTIVITY IN PATIENTS RECEIVING DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL OR TICAGRELOR
    Verdoia, Monica
    Daffara, Veronica
    Marino, Paolo
    De Luca, Giuseppe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 215 - 215
  • [38] Prognostic implications of high platelet reactivity in patients with diabetes mellitus and coronary artery disease on chronic dual antiplatelet therapy
    Angiolillo, D. J.
    Bernardo, E.
    Sabate, M.
    Jimenez-Quevedo, P.
    Palazuelos, J.
    Hernandez-Antolin, R.
    Costa, M. A.
    Bass, T. A.
    Macaya, C.
    Fernandez-Ortiz, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 187 - 187
  • [39] A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy
    Fabbri, Alessia
    Marcucci, Rossella
    Gori, Anna Maria
    Giusti, Betti
    Paniccia, Rita
    Balzi, Daniela
    Barchielli, Alessandro
    Valente, Serafina
    Giglioli, Cristina
    Abbate, Rosanna
    Gensini, Gian Franco
    THROMBOSIS RESEARCH, 2015, 136 (03) : 613 - 619
  • [40] Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Barbieri, Lucia
    Pergolini, Patrizia
    Verdoia, Monica
    Rolla, Roberta
    Nardin, Matteo
    Marino, Paolo
    Bellomo, Giorgio
    Suryapranata, Harry
    De Luca, Giuseppe
    VASCULAR PHARMACOLOGY, 2016, 79 : 11 - 15